Product overview

Name Tenidap
Alternative names CP 66248
Purity >98%
Description Kir2.3 channel agonist
Write Your Own Review
You're reviewing:Tenidap
Rate this item:

Biological Data

Biological description Kir2.3 channel agonist (EC50 = 402 nM). Exhibits little or no activity at hKir2.1 and Kv1.5 channels. Also inhibits COX-1 and COX-2 (IC50 values are <0.03 and 1.2 µM respectively). Displays anti-inflammatory and neuroprotective properties.

Solubility & Handling

Storage instructions +4°C
Solubility overview Soluble in DMSO (100mM)
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Purity >98%
Chemical name 5-Chloro-2,3-dihydro-3-(hydroxy-2-thienylmethylene)-2-oxo-1H-indole-1-carboxamide
Molecular Weight 320.75
Chemical structure Tenidap  [120210-48-2] Chemical Structure
Molecular Formula C14H9N2O3SCl
CAS Number 120210-48-2
PubChem identifier 54683953
SMILES O=C1N(C(N)=O)C2=CC=C(Cl)C=C2/C1=C(O)\C3=CC=CS3
InChi InChI=1S/C14H9ClN2O3S/c15-7-3-4-9-8(6-7)11(13(19)17(9)14(16)20)12(18)10-2-1-5-21-10/h1-6,19H,(H2,16,20)
InChiKey LXIKEPCNDFVJKC-QXMHVHEDSA-N

References for Tenidap

References are publications that support the biological activity of the product
  • Tenidap, an agonist of the inwardly rectifying K+ channel Kir2.3, delays the onset of cortical epileptiform activity in a model of chronic temporal lobe epilepsy.

    Xu L et al (2013) Neurol Res 35(6) : 561-7.
  • Tenidap is neuroprotective in a pilocarpine rat model of temporal lobe epilepsy.

    Tang XH et al (2013) Chin Med J (Engl) 126(10) : 1900-5.
  • Tenidap, a novel anti-inflammatory agent, is an opener of the inwardly rectifying K+ channel hKir2.3.

    Liu Y et al (2002) Eur J Pharmacol 435(2-3) : 153-60.
  • Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.

    Kirchner T et al (1997) J Pharmacol Exp Ther 282(2) : 1094-101.

4 Item(s)